{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:26:22Z","timestamp":1707524782846},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,18]]},"DOI":"10.7759\/cureus.30419","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T12:16:32Z","timestamp":1666095392000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Pyoderma Gangrenosum: Stabilized on Colchicine and Tumor Necrosis Factor (TNF) Inhibitor"],"prefix":"10.7759","author":[{"given":"Salha","family":"Hakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Alharthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer Mohammed  M","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Dermatology","author":"Bolognia J","year":"2018","unstructured":"Bolognia J, Schaffer J, Cerroni J. Dermatology. Elsevier, Philadelphia, PA; 2018. 1:459-63."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments","volume":"23","author":"Maronese CA","year":"2022","unstructured":"Maronese CA, Pimentel MA, Li MM, Genovese G, Ortega-Loayza AG, Marzano AV. Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments. Am J Clin Dermatol. 2022, 23:615-34. 10.1007\/s40257-022-00699-8","journal-title":"Am J Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-200109000-00015","article-title":"Management strategies for pyoderma gangrenosum: case studies and review of literature","volume":"47","author":"Rozen SM","year":"2001","unstructured":"Rozen SM, Nahabedian MY, Manson PN. Management strategies for pyoderma gangrenosum: case studies and review of literature. Ann Plast Surg. 2001, 47:310-5. 10.1097\/00000637-200109000-00015","journal-title":"Ann Plast Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/09546631003686069","article-title":"Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification","volume":"22","author":"Marzano AV","year":"2011","unstructured":"Marzano AV, Trevisan V, Lazzari R, Crosti C. Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification. J Dermatolog Treat. 2011, 22:254-60. 10.3109\/09546631003686069","journal-title":"J Dermatolog Treat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts","volume":"154","author":"Maverakis E","year":"2018","unstructured":"Maverakis E, Ma C, Shinkai K, et al.. Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts. JAMA Dermatol. 2018, 154:461-6. 10.1001\/jamadermatol.2017.5980","journal-title":"JAMA Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00311.x","article-title":"Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum","volume":"111","author":"Adachi Y","year":"1998","unstructured":"Adachi Y, Kindzelskii AL, Cookingham G, Shaya S, Moore EC, Todd RF 3rd, Petty HR. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol. 1998, 111:259-68. 10.1046\/j.1523-1747.1998.00311.x","journal-title":"J Invest Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: a comprehensive review","volume":"13","author":"Ahronowitz I","year":"2012","unstructured":"Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012, 13:191-211. 10.2165\/11595240-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5978","article-title":"The association of age with clinical presentation and comorbidities of pyoderma gangrenosum","volume":"154","author":"Ashchyan HJ","year":"2018","unstructured":"Ashchyan HJ, Butler DC, Nelson CA, et al.. The association of age with clinical presentation and comorbidities of pyoderma gangrenosum. JAMA Dermatol. 2018, 154:409-13. 10.1001\/jamadermatol.2017.5978","journal-title":"JAMA Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.028","article-title":"Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent","volume":"69","author":"Li J","year":"2013","unstructured":"Li J, Kelly R. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent. J Am Acad Dermatol. 2013, 69:565-9. 10.1016\/j.jaad.2013.05.028","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15539","article-title":"Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review","volume":"60","author":"Hrin ML","year":"2021","unstructured":"Hrin ML, Bashyam AM, Huang WW, Feldman SR. Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review. Int J Dermatol. 2021, 60:e486-92. 10.1111\/ijd.15539","journal-title":"Int J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1506083","article-title":"Biologic and small-molecule medications in the management of pyoderma gangrenosum","volume":"30","author":"McKenzie F","year":"2019","unstructured":"McKenzie F, Cash D, Gupta A, Cummings LW, Ortega-Loayza AG. Biologic and small-molecule medications in the management of pyoderma gangrenosum. J Dermatolog Treat. 2019, 30:264-76. 10.1080\/09546634.2018.1506083","journal-title":"J Dermatolog Treat"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2009.00002","article-title":"Pyoderma gangrenosum: common pitfalls in management and a stepwise, evidence-based, therapeutic approach","volume":"13 Suppl 1","author":"Prajapati V","year":"2009","unstructured":"Prajapati V, Man J, Brassard A. Pyoderma gangrenosum: common pitfalls in management and a stepwise, evidence-based, therapeutic approach. J Cutan Med Surg. 2009, 13 Suppl 1:S2-11. 10.2310\/7750.2009.00002","journal-title":"J Cutan Med Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000079897","article-title":"Treatment of Pyoderma gangrenosum with low-dose colchicine","volume":"209","author":"Kontochristopoulos GJ","year":"2004","unstructured":"Kontochristopoulos GJ, Stavropoulos PG, Gregoriou S, Zakopoulou N. Treatment of Pyoderma gangrenosum with low-dose colchicine. Dermatology. 2004, 209:233-6. 10.1159\/000079897","journal-title":"Dermatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90801-3","article-title":"Treatment of pyoderma gangrenosum with colchicine","volume":"345","author":"Paolini O","year":"1995","unstructured":"Paolini O, Hebuterne X, Flory P, Charles F, Rampal P. Treatment of pyoderma gangrenosum with colchicine. Lancet. 1995, 345:1057-8. 10.1016\/S0140-6736(95)90801-3","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115528-refractory-pyoderma-gangrenosum-stabilized-on-colchicine-and-tumor-necrosis-factor-tnf-inhibitor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:06Z","timestamp":1707508326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115528-refractory-pyoderma-gangrenosum-stabilized-on-colchicine-and-tumor-necrosis-factor-tnf-inhibitor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.30419","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,18]]}}}